Palo Alto Investors LP Abiomed Inc Transaction History

Palo Alto Investors LP

$727 Million
Q3 2024

20 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 14, 2022	SELL	$242.49 - $301.46 $883,391 - $1.1 Million	-3,643 Reduced 0.74%	490,754 $121 Million
Q1 2022 May 16, 2022	SELL	$277.25 - $366.29 $6.83 Million - $9.02 Million	-24,636 Reduced 4.75%	494,397 $164 Million
Q4 2021 Feb 14, 2022	SELL	$300.63 - $371.35 $9.26 Million - $11.4 Million	-30,787 Reduced 5.6%	519,033 $186 Million
Q3 2021 Nov 15, 2021	SELL	$310.19 - $376.2 $10.6 Million - $12.8 Million	-34,113 Reduced 5.84%	549,820 $179 Million
Q2 2021 Aug 16, 2021	BUY	$262.71 - $351.17 $2.29 Million - $3.06 Million	8,700 Added 1.51%	583,933 $182 Million
Q1 2021 May 17, 2021	BUY	$285.92 - $355.13 $5.32 Million - $6.61 Million	18,600 Added 3.34%	575,233 $183 Million
Q4 2020 Feb 16, 2021	BUY	$251.88 - $324.2 $13.2 Million - $17.1 Million	52,600 Added 10.44%	556,633 $180 Million
Q3 2020 Nov 16, 2020	BUY	$255.22 - $317.0 $2.99 Million - $3.71 Million	11,700 Added 2.38%	504,033 $140 Million
Q2 2020 Aug 14, 2020	SELL	$141.4 - $257.09 $1.47 Million - $2.68 Million	-10,412 Reduced 2.07%	492,333 $119 Million
Q1 2020 May 15, 2020	SELL	$130.51 - $196.01 $8.02 Million - $12 Million	-61,423 Reduced 10.89%	502,745 $73 Million
Q4 2019 Feb 14, 2020	SELL	$159.31 - $223.54 $14.4 Million - $20.2 Million	-90,260 Reduced 13.79%	564,168 $96.2 Million
Q3 2019 Nov 14, 2019	SELL	$175.89 - $279.23 $9.13 Million - $14.5 Million	-51,926 Reduced 7.35%	654,428 $116 Million
Q2 2019 Aug 14, 2019	BUY	$250.96 - $284.94 $1.93 Million - $2.19 Million	7,700 Added 1.1%	706,354 $184 Million
Q1 2019 May 15, 2019	BUY	$276.39 - $362.25 $2.52 Million - $3.3 Million	9,104 Added 1.32%	698,654 $200 Million
Q4 2018 Feb 14, 2019	SELL	$281.08 - $444.25 $5.44 Million - $8.6 Million	-19,367 Reduced 2.73%	689,550 $224 Million
Q3 2018 Nov 14, 2018	SELL	$354.53 - $449.75 $64.3 Million - $81.6 Million	-181,392 Reduced 20.37%	708,917 $319 Million
Q2 2018 Aug 14, 2018	SELL	$278.07 - $446.21 $127 Million - $204 Million	-456,351 Reduced 33.89%	890,309 $364 Million
Q1 2018 May 15, 2018	SELL	$192.49 - $295.85 $46 Million - $70.6 Million	-238,753 Reduced 15.06%	1,346,660 $392 Million
Q4 2017 Feb 14, 2018	SELL	$168.78 - $199.74 $59.1 Million - $69.9 Million	-349,887 Reduced 18.08%	1,585,413 $297 Million
Q3 2017 Nov 14, 2017	BUY	$145.39 - $168.6 $281 Million - $326 Million	1,935,300	1,935,300 $326 Million

Others Institutions Holding ABMD

# of Institutions

Shares Held

137K

Call Options Held

Put Options Held

View Full List

About ABIOMED INC

Ticker ABMD
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 45,460,900
Description
Abiomed, Inc. engages in the research, development, and sale of medical devices to assist or replace the pumping function of the failing heart. It also provides a continuum of care to heart failure patients. The company offers Impella 2.5, a percutaneous micro heart pump with integrated motor and sensors; and Impella CP, a device for use by inte...

More about ABMD

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Palo Alto Investors LP, based on Form 13F filings with the SEC.

News

Stay updated on Palo Alto Investors LP with notifications on news.

Account